High Q Technologies Partners with Creative Biostructure to Scale Quantum-Enabled EPR Protein Mapping
AI-summarised brief · reviewed before publication
High Q Technologies, a Waterloo spin‑out, partnered with Creative Biostructure, a New York CRO serving over 3,000 customers in 60 countries. The agreement integrates High Q’s quantum‑enabled pulsed EPR spectrometer, FATHOM, into Creative Biostructure’s workflow to map flexible and disordered protein regions with nanoscale precision. Using superconducting quantum‑sensing resonators, FATHOM captures multiple conformations of intrinsically disordered proteins such as amyloid‑β and tau, which are hard to resolve with Cryo‑EM, NMR or X‑ray methods. The system automates sample handling, cutting acquisition time from weeks to hours and letting pharmaceutical teams validate AlphaFold predictions before Cryo‑EM studies. Backed by Canada’s National Quantum Strategy, FedDev Ontario, the Strategic Innovation Fund and Quantum Valley Investments, first commercial units are slated for Europe later this year.
💡 Why It Matters
- · It gives drug developers a rapid, quantum‑level check on protein dynamics, preventing costly dead‑ends in later, high‑expense imaging stages.